Topic: Endo Pharmaceuticals Holdings Inc.
Endo Pharmaceuticals today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Fortesta (testosterone) 2% Gel for men diagnosed with low testosterone (Low T), also known as hypogonadism.. ...
From Around the Web
Video Gallery
-
Penwest Pharmaceuticals Gains on Endo Pharmaceutic...
"Penwest Pharmaceuticals Co (PPCO) is on the rise on news ...2010-08-10 -
Endo's Holveck Calls Qualitest Purchase ...
Sept. 28 (Bloomberg) -- David Holveck, chief executive officer of Endo ...2010-09-28 -
Endo Pharma Buying American Medical Systems ...
Endo Pharmaceuticals Holdings Inc. (ENDP) is buying urology and pelvic ...2011-04-11
